Emergent players in renovascular disease

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Pathophysiology

Background:

• Renovascular disease (RVD) is a frequent cause of secondary hypertension.
• Recent trials show limited success with renal revascularization, prompting deeper investigation into chronic ischemic kidney injury.
• Understanding RVD has evolved from a hemodynamic issue to a pro-inflammatory and pro-fibrotic condition.

Purpose of the Study:

• To review the complex pathophysiological mechanisms of chronic ischemic kidney injury in RVD.
• To highlight the role of inflammation, fibrosis, and cellular damage.
• To discuss advancements in diagnostics and therapeutics for RVD.

Main Methods:

• Literature review of recent clinical trials and research studies on renovascular disease.
• Analysis of pathophysiological pathways including inflammation, fibrosis, mitochondrial injury, senescence, and microvascular remodeling.
• Examination of novel diagnostic and therapeutic strategies.

Main Results:

• Chronic ischemic kidney injury involves intricate interactions of inflammation, fibrosis, mitochondrial damage, cellular senescence, and microvascular remodeling.
• RVD is influenced by systemic conditions such as metabolic syndrome, hypertension, diabetes, and hyperlipidemia.
• Emerging diagnostic tools and targeted therapies show promise in preclinical and early clinical research.

Conclusions:

• The understanding of RVD has shifted towards recognizing it as a complex inflammatory and fibrotic pathology.
• Early detection and targeted therapies are crucial for managing chronic ischemic kidney injury.
• Further research is needed to translate promising preclinical findings into effective clinical treatments for RVD.